首页> 外国专利> Improvements relating to the purification of labile enzymes contaminated with hemolysiní¬o

Improvements relating to the purification of labile enzymes contaminated with hemolysiní¬o

机译:与纯化被溶血素污染的不稳定酶有关的改进

摘要

Labile enzymes contaminated with haemolysin-O are purified by treating aqueous solutions thereof with a solution of cholesterol in an organic liquid protein-precipitant, removing the resulting precipitate, adding water and separating the insoluble cholesterol-haemolysin complex and free cholesterol from the enzyme solution; the amount of cholesterol should be sufficient to combine with all the haemolysin, i.e. at least 0.01 mg. (and preferably 0.2-2.0 mg.) per 10,000 Bernheimer units thereof; the temperature is kept below 5 DEG C. throughout. The process is especially applicable to enzymes obtained by bacterial fermentation, with or without preliminary purification. The organic liquid may be ethanol, methanol, acetone or ether; another liquid may be added to increase the solubility of the cholesterol. Sufficient liquid protein-precipitant should be added to give a concentration of 5-60 per cent by volume; when the concentration is greater than 40 per cent the temperature should be kept below 0 DEG C., and in general it is desirable to keep the temperature within 5 DEG C. of the freezing point of the mixture. By suitable control of concentration, ionic strength, temperature, pH and amount of organic solvent it is possible to retain some non-enzymatic protein material in solution when all the enzymes have been precipitated. To ensure that all the haemolysin is in its reduced form it is desirable to add a mercapto compound before the cholesterol. The cholesterol complex is often too fine to be readily separated from the reconstituted solution and it is therefore advantageous to add protamine (0.005-0.02 parts by weight of total N in the solution), thereby precipitating non-enzymatic proteins in addition; this method is described in Specification 715,572. Examples are given of the purification of a mixture of streptokinase and streptodornase, with and without protamine treatment.
机译:通过用胆固醇在有机液体蛋白质沉淀剂中的溶液处理水溶液,纯化被溶血素-O污染的不稳定酶,去除所得沉淀物,加水并从酶溶液中分离出不溶性胆固醇-溶血素复合物和游离胆固醇;胆固醇的量应足以与所有溶血素结合,即至少0.01 mg。 (每10,000个Bernheimer单位)(优选0.2-2.0mg。);温度始终保持在5℃以下。该方法特别适用于通过细菌发酵获得的酶,无论是否进行初步纯化。有机液体可以是乙醇,甲醇,丙酮或乙醚;有机液体可以是乙醇。可以添加另一种液体以增加胆固醇的溶解度。应添加足够的液态蛋白质沉淀剂,使其浓度为5-60%(按体积计);当浓度大于40%时,温度应保持在0℃以下,并且通常希望将温度保持在混合物凝固点的5℃以内。通过适当控制浓度,离子强度,温度,pH和有机溶剂的量,当所有酶沉淀后,可以在溶液中保留一些非酶蛋白物质。为了确保所有的溶血素处于还原形式,需要在胆固醇之前加入巯基化合物。胆固醇复合物通常太细而不能轻易地从重构溶液中分离出来,因此加入鱼精蛋白(溶液中总氮的0.005-0.02重量份)是有利的,从而另外沉淀了非酶蛋白。规范715,572中描述了此方法。给出了在有或没有鱼精蛋白处理的情况下链激酶和链霉菌糖酶的混合物的纯化的实例。

著录项

  • 公开/公告号GB715930A

    专利类型

  • 公开/公告日1954-09-22

    原文格式PDF

  • 申请/专利权人 AMERICAN CYANAMID COMPANY;

    申请/专利号GB19520017979

  • 发明设计人

    申请日1952-07-16

  • 分类号C07K14/315;

  • 国家 GB

  • 入库时间 2022-08-23 23:46:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号